CD28 signaling causes a sustained down-regulation of I kappa B alpha which can be prevented by the immunosuppressant rapamycin.

This publication has 18 references indexed in Scilit:

• The B7 and CD28 receptor families
  Immunology Today, 1994
• The I kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors.
  Genes & Development, 1993
• Regulation of the NF-ηB/rel transcription factor and IηB inhibitor system
  Current Opinion in Cell Biology, 1993
• The Role of the CD28 Receptor During T Cell Responses to Antigen
  Annual Review of Immunology, 1993
• Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1.
  The Journal of Experimental Medicine, 1993
• The precursor of NF-κB p50 has IκB-like functions
  Cell, 1992
• Cyclosporin A, FK-506, and Rapamycin: Pharmacologic Probes of Lymphocyte Signal Transduction
  Annual Review of Immunology, 1992
• CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones
  Nature, 1992
• The effect of the immunosuppressant FK‐506 on alternate pathways of T cell activation
  European Journal of Immunology, 1991
• Regulation of Interleukin-2 Gene Enhancer Activity by the T Cell Accessory Molecule CD28
  Science, 1991